@mastersthesis{pharma:2873, author = {{Koren, Sara}}, title = {{Provođenje mjera minimizacije rizika primjene fluoropirimidina u Republici Hrvatskoj}}, } @article{mef:6693, author = {{Božina, Nada and Šušak Sporiš, Ivana and Klarica Domjanović, Iva and Ganoci, Lana and Šimičević, Livija and Lovrić, Mila and Čolak Romić, Zrinka and Petelin Gadže, Željka and Trkulja, Vladimir}}, title = {{Bearing variant alleles at uridine glucuronosyltransferase polymorphisms UGT2B7 -161C > T (rs7668258) or UGT1A4*3 c.142 T > G (rs2011425) has no relevant consequences for lamotrigine troughs in adults with epilepsy}}, } @mastersthesis{pharma:2819, author = {{Mustapić, Matej}}, title = {{Antinociceptivni učinak botulinum toksina tipa A u animalnom modelu boli uzrokovane formalinom}}, } @article{mef:7204, author = {{Šimičević, Livija and Slišković, Ana Marija and Vrkić Kirhmajer, Majda and Ganoci, Lana and Holik, Hrvoje and Palić, Jozefina and Samardžić, Jure and Božina, Tamara}}, title = {{Risk Factors for Rivaroxaban-Related Bleeding Events - Possible Role of Pharmacogenetics: Case Series}}, } @article{mef:6511, author = {{Božina, Tamara and Ganoci, Lana and Karačić, Ena and Šimičević, Livija and Vrkić-Kirhmajer, Majda and Klarica-Domjanović, Iva and Križ, Tena and Sertić, Zrinka and Božina, Nada}}, title = {{ABCG2 and SLCO1B1 gene polymorphisms in the Croatian population}}, } @mastersthesis{pharma:2523, author = {{Petreković, Sandra}}, title = {{Učestalost polimorfizama CYP3A4*1B, CYP3A4*22 i CYP3A5*3 u hrvatskoj populaciji}}, } @mastersthesis{pharma:2636, author = {{Krsmanović, Dora}}, title = {{Genotipizacija CYP2C9 u kliničkoj praksi}}, } @mastersthesis{pharma:2228, author = {{Karačić, Ena}}, title = {{Polimorfizmi gena ABCG2 i SLCO1B1 kao rizični čimbenici terapije statinima (ABCG2 and SLCO1B1 gene polymorphisms as risk factors to statin therapy}}, } @article{mef:4062, author = {{Ganoci, Lana and Trkulja, Vladimir and Živković, Maja and Božina, Tamara and Šagud, Marina and Lovrić, Mila and Božina, Nada}}, title = {{ABCB1, ABCG2 and CYP2D6 polymorphism effects on disposition and response to long-acting risperidone}}, } @article{mef:2550, author = {{Božina, Nada and Vrkić Kirhmajer, Majda and Šimičević, Livija and Ganoci, Lana and Mirošević Skvrce, Nikica and Klarica Domjanović, Iva and Merčep, Iveta}}, title = {{Use of pharmacogenomics in elderly patients treated for cardiovascular diseases}}, } @phdthesis{mef:6284, author = {{Ganoci, Lana}}, title = {{Utjecaj farmakogenetičkih varijacija CYP2D6 i ABCB1 na liječenje pripravkom risperidona s produljenim oslobađanjem }}, } @article{mef:2710, author = {{Živković, Maja and Mihaljević-Peleš, Alma and Muck-Šeler, Dorotea and Šagud, Marina and Ganoci, Lana and Vlatković, Suzana and Nikolac Perković, Matea and Tudor, Lucija and Božina, Nada and Pivac, Nela}}, title = {{The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study}}, } @article{medri:5208, author = {{Šimić, Iveta and Potočnjak, Ines and Kraljičković, Iva and Stanić Benić, Mirjana and Čegec, Ivana and Juričić Nahal, Danica and Ganoci, Lana and Božina, Nada}}, title = {{CYP2D6 *6/*6 genotype and drug interactions as cause of haloperidol induced extrapyramidal symptoms}}, }